Clinical studies recruiting near Huntsville

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · Tennessee Valley Neurological Associates PC · AbbVie · NCT06602479 A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphospha
Phase 2 · Apogee Clinical Research, LLC · R1 Therapeutics · NCT06712654 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Clearview Cancer Institute · Eli Lilly and Company · NCT07218380 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Clearview Cancer Institute (Crestwood) · Pfizer · NCT07028853 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Nephrology Consultants, LLC · Boehringer Ingelheim · NCT07355296 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Heart Center Research LLC · Amgen · NCT07037433 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Clearview Cancer Institute · Eli Lilly and Company · NCT06890598 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Apogee Clinical Research · Boehringer Ingelheim · NCT06531824 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Apogee Clinical Research, LLC · Biogen · NCT06962800 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Apogee Clinical Research · Boehringer Ingelheim · NCT07220083 Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing
NA · Huntsville Heart Center · University of British Columbia · NCT04634240 A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · Medovation Research · Eli Lilly and Company · NCT06338995 Pan Tumor Rollover Study
Phase 2 · Local Institution - 0220 · Bristol-Myers Squibb · NCT03899155 A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With
Phase N/A · Rehabilitation & Neurological Services · Eli Lilly and Company · NCT06566170 Prevail Global Study
NA · Huntsville Hospital · Medtronic Vascular · NCT06535854 A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · Clearview Cancer Institute · Eli Lilly and Company · NCT06119581 A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Te
Phase 2 · Clearview Cancer Institute - Huntsville - Cci Drive /ID# 278 · AbbVie · NCT07023289 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Heart Center Research Llc · Novartis Pharmaceuticals · NCT07517263 A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myelom
Phase 2 · Clearview Cancer Institute · C4 Therapeutics, Inc. · NCT07284758 Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
Phase 4 · Heart Center Research, LLC · Heart Center Research, LLC · NCT06218199 Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Maj
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT06966401 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants W
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT06911112 Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolesce
NA · UAB Huntsville Regional Medical Campus · University of Alabama at Birmingham · NCT05437588 Pivotal Study for the Cardiac Performance System (CPS)
Phase N/A · Huntsville Hospital Heart Center · Sensydia Corporation · NCT06870591 Effects of Ashwagandha Extract on Stress Levels
NA · Nutraceuticals Research Institute · Nutraceuticals Research Institute · NCT06793891 OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio
Phase 3 · Heart Center Research LLC · Amgen · NCT07136012 VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Phase 3 · Metro Infectious Disease Consultants · Vedanta Biosciences, Inc. · NCT06237452 A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices
Phase N/A · Huntsville Hospital · Teleflex · NCT06604039 A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Phase 3 · Medical Affiliated Research Center · Pfizer · NCT07282665

Look up another city

Look up another condition